The initial reporter complained of an issue with a cobas p512 pre-analytical system.The customer repeated 250 patient samples with elecsys hcg+b (hcg + b) results of < 10 iu/l from the p512 system.During the run on (b)(6) 2023, discrepant results were identified for 1 patient.The initial result was < 0.200 iu/l with a data flag.The repeated results were 14.1 iu/l, 14.4 iu/l, and 14.47 iu/l.Based on these results, the customer alleges cross-contamination occurred.
|
The primary tube transporter (ptt) of the output sorter shows fallen tubes and loose sealing foils.It was noted that an incorrect open group was activated in the system.The decapper unit had tape around the upper edge of the waste funnel; this indicates use outside of specifications.A loose gray cap was also observed.The customer uses a manual pre-analytic workflow allowing for multiple possibilities for contamination.These possibilities could be avoided by using an automated pre-analytic workflow for which the customer has instrumentation installed but is not using.Manual blood drawing syringe needle removal and lithium heparin manual de-capping and re-capping are critical workflow steps that can contaminate the syringe nozzle, the rim of the tube, and the inside of the tube.There is no evidence that the cobas p 512 instrument caused cross-contamination.The investigation did not identify a product problem.
|